Aspirin Response in High Risk Patients With Coronary Artery Disease
Launched by UNIVERSITY OF AARHUS · Jun 27, 2011
Trial Information
Current as of July 21, 2025
Unknown status
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Coronary artery disease verified by coronary angiogram
- • Treatment with aspirin 75 mg/d for at least the previous 7 days
- • Previous myocardial infarction more than one year ago (groups with previous myocardial infarction)
- • Type 2 diabetes mellitus treated with oral antidiabetics and/or insulin (groups with type 2 diabetes mellitus)
- • Renal insufficiency; glomerular filtration rate \<60 ml/min at the time of blood sampling (groups with renal insufficiency)
- Exclusion Criteria:
- • Treatment with NSAIDs, clopidogrel, ticlopidine, dipyridamole, warfarin or any other drugs known to affect platelet function
- • Ischemic vascular event within the previous 12 months
- • Revascularization (angioplasty or coronary by-pass graft surgery) within the previous 12 months
- • Platelet count \<120 x 10\^9/L or \>450 x 10\^9/L
- • For patients without diabetes: fast glucose \>7 mmol/L
- • Unable to give informed consent
About University Of Aarhus
The University of Aarhus, a prestigious research institution located in Denmark, is dedicated to advancing medical science through innovative clinical trials. With a strong emphasis on interdisciplinary collaboration, the university fosters an environment that encourages cutting-edge research and the development of novel therapeutic interventions. Committed to ethical standards and patient safety, the University of Aarhus aims to contribute to the global body of medical knowledge while enhancing healthcare outcomes through rigorous scientific inquiry and evidence-based practices.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Aarhus N, , Denmark
Patients applied
Trial Officials
Anne-Mette Hvas, MD, Ph.D
Principal Investigator
Department of Clinical Biochemistry, Aarhus University Hospital, Skejby, Denmark
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials